focusIR May 2024 Investor Webinar: Blue Whale, Kavango, Taseko Mines & CQS Natural Resources. Catch up with the webinar here.

Less Ads, More Data, More Tools Register for FREE
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied Materials
Stephen Yiu, FM at WS Blue Whale, discusses Nvidia, Visa/Mastercard, Lam Research & Allied MaterialsView Video
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to mining
Ben Turney, CEO at Kavango Resources, explains the company's progress from exploration to miningView Video

Latest Share Chat

UPDATE 2-London stocks slip after glum GDP data, end with second week of gains

Fri, 10th Dec 2021 10:09

* AstraZeneca falls on price target cut

* UK economy barely grew in October

* Data raises doubts around rate hikes

* FTSE 100 off 0.4%, FTSE 250 down 0.9%
(Adds comments, updates prices throughout)

By Bansari Mayur Kamdar

Dec 10 (Reuters) - UK's FTSE 100 and mid caps indexes
slipped for a third straight session on Friday after data
pointed to stalling economic growth in Britain, even before the
emergence of the Omicron coronavirus variant, but ended their
second week in the black.

The benchmark FTSE 100 index eased 0.4% pressured by
the healthcare sector after heavyweight drugmaker
AstraZeneca fell 2.0% after Berenberg cut its price
target on the stock.

The main index clocked its biggest weekly gain in eight
months, boosted by a strong recovery in mining stocks.

"We're seeing a flight to safety with defensive names like
British American Tobacco on the front foot," said Justin
McQueen, market analyst at DailyFX.

"The sort of news around Omicron and the government
announcing its plan B and suggestions around plan C does put the
final nail in the coffin for a rate rise next week."

Data showed Britain's economy grew by a weaker-than-expected
0.1% in October, leaving it 0.5% smaller than it was in February
2020, just before the country went into its first COVID-19
lockdown.

"The big drop in people visiting pubs, bars and restaurants
doesn't bode well for the idea that we're all rediscovering our
freedom post-lockdown. Perhaps this catalyst has now played out
and people are yearning for the warmth of their home during the
autumn and winter instead," said Russ Mould, investment director
at AJ Bell.

The domestically focussed mid-cap index fell 0.9%,
after Ashmore Group dropped 2.7% as Goldman Sachs
downgraded the asset manager to "neutral".

The numbers further raised doubts about a December rate hike
after Prime Minister Boris Johnson this week announced new
coronavirus guidelines ordering people to work from home, wear
masks in public places and use vaccine passes for bit public
events.

Capping losses on the main index, miners
gained 0.7% tracking copper prices, and defensive stocks such as
consumer staples, which tend to be less sensitive to the
economic climate, also rose.

British American Tobacco gained nearly 2.5% after a
Wall Street Journal report that said the U.S. Senate was
dropping a proposal to impose higher taxes on vaping, oral
nicotine and other NGPs.
(Reporting by Bansari Mayur Kamdar in Bengaluru
Editing by Subhranshu Sahu, Amy Caren Daniel and Frances Kerry)

Related Shares

More News
Today 08:18

TOP NEWS: AstraZeneca eyes new era of growth with bold new revenue aim

(Alliance News) - AstraZeneca PLC on Tuesday set out its ambition to achieve USD80 billion in annual revenue by the end of the decade as it signalled ...

Today 07:52

LONDON BRIEFING: AstraZeneca plots "new era of growth"; SSP confident

(Alliance News) - London's FTSE 100 is called to open lower on Tuesday, following a mixed close in New York overnight, and tepid trade in Asia.

Today 07:34

AstraZeneca lays out plans to hit $80bn in revenues by 2030

(Sharecast News) - AstraZeneca has unveiled medium-term growth targets to nearly double group revenues by the end of the decade as it predicts signifi...

20 May 2024 11:55

LONDON MARKET MIDDAY: Gold shines amid interest rate cut hopes

(Alliance News) - Stock prices in London got a boost at midday on Monday, as investors eye a key UK inflation reading later in the week, which is expe...

20 May 2024 08:24

TOP NEWS: AstraZeneca plans to build manufacturing plant in Singapore

(Alliance News) - AstraZeneca PLC on Monday announced plans for a USD1.5 billion manufacturing facility in Singapore to produce antibody drug conjugat...

Login to your account

Don't have an account? Click here to register.

Quickpicks are a member only feature

Login to your account

Don't have an account? Click here to register.